Abstract
The treatment of co-existing hypertension is vital to reduce morbidity and mortality from complications of diabetes. There is a vast array of evidence on the subject and the choice of antihypertensive medication is extensive. We have reviewed the evidence for blood pressure (BP) control in diabetes, and examined the evidence to support the use of each class of drug, concentrating on patients without nephropathy or microalbuminuria. Control of BP should be the overriding aim, and requires over time more than one drug in most patients. The weight of evidence suggests that BP-lowering per se is more important than the actual agent used.
Original language | English |
---|---|
Pages (from-to) | 252-256 |
Number of pages | 4 |
Journal | British Journal of Diabetes and Vascular Disease |
Volume | 3 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Jul 2003 |